| Literature DB >> 24581111 |
S T Yavagal1, Niteen Deshpande2, Parag Admane3.
Abstract
Resting echocardiography is the most important tool for diagnosing valvular heart disease. However, treatment planning in valvular heart diseases may require additional information in some patients, particularly asymptomatic patients with severe valve disease or symptomatic patients with moderate disease. Stress echocardiography provides invaluable information in these situations and aids decision making. Stress echocardiography is performed using either physical stress or dobutamine stress and various valve parameters are monitored during the stress. Further, the ventricular performance, which is an important determinant of outcome in valve disease is also closely monitored during stress which helps immensely in planning the intervention. Lastly, possibility of associated coronary artery disease can also be evaluated, especially in the elderly. This article discusses the role of stress evaluation in assessment of valve disease in the commonly encountered clinical situations.Entities:
Mesh:
Year: 2014 PMID: 24581111 PMCID: PMC3946507 DOI: 10.1016/j.ihj.2013.12.051
Source DB: PubMed Journal: Indian Heart J ISSN: 0019-4832
Fig. 1Evaluation algorhythm for severe aortic stenosis with LV dysfunction.
Fig. 2Pre and post-exercise mitral stenosis. Asymptomatic patient of moderate mitral stenosis and resting peak and mean gradient of 9 and 4 mmHg with PASP of 36 mmHg, following exercise on the modified Bruce protocol, post-exercise the peak and mean gradient increased to 26 and 17 mmHg and PASP TO 63 mmHg, thus indicating severe mitral stenosis.
Fig. 3Pre and post-exercise mitral regurgitation. A patient with moderate MR and moderate PH, following exercise on Bruce protocol for 4.5 min, patient developed severe breathlessness and PASP increased to 82 mmHg.
Fig. 4Calculation of tenting area and tenting distance calculation in patient of ischemic MR.
Stress echo in valvular disease at a glance.
| Valular lesion | Stress protocol | Parameters to be monitored | Criteria indicating significant lesion | ACC/AHA 2006 valvular disease guidelines |
|---|---|---|---|---|
| Asymptomatic AS | Treadmill or supine bicycle paddle Ex or dobutamine | Symptoms, blood pressure response, mean aortic valve gradient | Development of symptoms, <20 mmHg increase in BP, increase in mean gradient >18 mmHg | ACC/AHA class IIB with level of evidence B |
| Severe AS with LV dysfunction | Low dose dobutamine (upto 20 μg/kg/min) | Stroke volume, aortic valve area, transvalvular mean gradient | SV >20% | ACC/AHA class IIa level of evidence B |
| Asymtomatic severe AR | Exercise | Symptoms, functional capacity | Development of symptoms, decreased functional capacity | ACC/AHA class IIA with level of evidence B |
| Asymtomatic severe MS or symtomatic mild to moderate MS | Treadmill or supine paddle Ex or dobutamine | Transmitral gradient, pulmonary artery systolic pressure | Trans-mitral gradient >15 mm Hg during Ex, >18 mmHg during dobutamine, PASP >60 mmHg | ACC/AHA class I, level of evidence C |
| Rheumatic MR/degenerative MR | Treadmill or supine bicycle paddle Ex | LVEDV, LVESV, EF, PASP, symptoms, Ex tolerance | Development of symptoms, decreased Ex capacity, PASP >60 mmHg | ACC/AHA Class IIA, level of evidence C |
| Prosthetic valve | Exercise | Transvalvular gradient | >20 mmHg for aortic prosthesis, >12 mmHg for mitral prosthesis. |